: Central drug regulator CDSCO has initiated risk-based inspection of drug manufacturing units in six states following collection of 19 samples, including those of cough syrups, antipyretics and antibiotics in the wake of child deaths in Madhya Pradesh and Rajasthan, allegedly due to contaminated cough syrups.

The manufacturing units are in Himachal Pradesh, Uttarakhand, Gujarat, Tamil Nadu, Madhya Pradesh and Maharashtra, where 19 samples of different drugs were manufactured, sources in the health ministry said.

The inspections by the Central Drugs Standard Control Organisation (CDSCO) began Friday with the aim to identify gaps that may have led to drug quality failures and also suggest process improvement to avoid such incidents in future, the ministry said.

Additionally, a multidisci

See Full Page